Profile data is unavailable for this security.
About the company
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
- Revenue in USD (TTM)3.18m
- Net income in USD-116.85m
- Incorporated2020
- Employees143.00
- LocationQuantum-Si Inc29 Business Park DriveBRANFORD 06405United StatesUSA
- Phone+1 (203) 458-7100
- Fax+1 (302) 636-5454
- Websitehttps://www.quantum-si.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sol Gel Technologies Ltd | 18.97m | -8.99m | 187.20m | 34.00 | -- | 7.19 | -- | 9.87 | -3.23 | -3.23 | 6.81 | 9.34 | 0.4891 | -- | 2.25 | 557,941.20 | -23.17 | -29.32 | -27.70 | -33.19 | -- | -- | -47.37 | -138.22 | -- | -- | 0.00 | -- | 642.47 | -12.81 | 61.16 | -- | -68.01 | -- |
| Voyager Therapeutics Inc | 31.32m | -126.78m | 188.48m | 172.00 | -- | 0.8556 | -- | 6.02 | -2.17 | -2.17 | 0.5358 | 3.96 | 0.0877 | -- | 2.64 | 182,069.80 | -35.50 | -1.01 | -39.95 | -1.27 | -- | -- | -404.85 | -2.34 | -- | -- | 0.00 | -- | -68.00 | -5.18 | -149.12 | -- | -14.53 | -- |
| Humacyte Inc | 1.57m | -36.97m | 194.93m | 218.00 | -- | -- | -- | 124.08 | -0.2206 | -0.2206 | 0.011 | -0.0299 | 0.0152 | -- | -- | 7,206.42 | -35.84 | -41.46 | -46.28 | -45.37 | 60.53 | -- | -2,353.22 | -8,438.13 | 0.8965 | -- | 1.10 | -- | -- | -- | -34.24 | -- | -28.00 | -- |
| Neonc Technologies Holdings Inc | 59.99k | -48.88m | 199.42m | 3.00 | -- | -- | -- | 3,324.17 | -2.59 | -2.59 | 0.0032 | -0.6067 | 0.0176 | -- | -- | -- | -1,431.87 | -- | -- | -- | 33.34 | -- | -81,472.06 | -- | -- | -22.45 | -- | -- | 17.80 | -- | 20.26 | -- | -- | -- |
| CAMP4 Therapeutics Corp | 3.80m | -53.40m | 199.74m | 55.00 | -- | 3.08 | -- | 52.54 | -2.48 | -2.48 | 0.1746 | 1.25 | 0.0706 | -- | 1.81 | 69,127.27 | -99.11 | -- | -121.32 | -- | -- | -- | -1,404.47 | -- | -- | -- | 0.0013 | -- | 86.29 | -- | -5.07 | -- | -- | -- |
| Inhibikase Therapeutics Inc | 0.00 | -47.66m | 201.90m | 15.00 | -- | 1.71 | -- | -- | -1.15 | -1.15 | 0.00 | 0.9745 | 0.00 | -- | -- | 0.00 | -113.51 | -56.32 | -131.71 | -65.21 | -- | -- | -- | -1,965.97 | -- | -- | 0.00 | -- | -100.00 | -- | -44.62 | -- | -- | -- |
| Alector Inc | 69.05m | -107.74m | 204.11m | 156.00 | -- | 3.48 | -- | 2.96 | -1.07 | -1.07 | 0.6893 | 0.5371 | 0.1622 | -- | -- | 290,117.70 | -25.31 | -19.30 | -34.27 | -23.57 | -- | -- | -156.03 | -108.92 | -- | -- | 0.1428 | -- | 3.60 | 36.50 | 8.70 | -- | -39.33 | -- |
| Arcturus Therapeutics Holdings Inc | 97.60m | -66.71m | 204.85m | 174.00 | -- | 0.8744 | -- | 2.10 | -2.46 | -2.46 | 3.60 | 8.25 | 0.2989 | -- | 5.12 | 560,919.60 | -20.43 | -19.22 | -24.18 | -24.16 | -- | -- | -68.35 | -68.95 | -- | -- | 0.00 | -- | -8.69 | 48.93 | -172.30 | -- | -4.55 | -- |
| Surrozen Inc | 3.60m | -86.91m | 209.83m | 40.00 | -- | -- | -- | 58.22 | -19.76 | -19.76 | 0.6008 | -2.74 | 0.0507 | -- | 0.4882 | 90,100.00 | -122.36 | -60.48 | -134.33 | -68.26 | -- | -- | -2,411.38 | -993.19 | -- | -- | -- | -- | -- | -- | -47.68 | -- | -55.92 | -- |
| Silence Therapeutics plc | 25.81m | -65.01m | 210.19m | 115.00 | -- | 3.06 | -- | 8.14 | -0.462 | -0.462 | 0.1831 | 0.5227 | 0.1383 | -- | 124.98 | -- | -34.83 | -39.00 | -39.01 | -48.09 | 91.20 | 55.91 | -251.86 | -203.50 | -- | -- | 0.00 | -- | 36.71 | 168.26 | 16.45 | -- | 78.99 | -- |
| Heron Therapeutics Inc | 155.10m | -13.58m | 210.87m | 122.00 | -- | 30.02 | -- | 1.36 | -0.0809 | -0.0809 | 0.9199 | 0.0812 | 0.6604 | 0.6977 | 2.09 | 1,271,287.00 | -5.78 | -50.09 | -9.22 | -70.09 | 73.92 | 56.53 | -8.75 | -136.13 | 1.78 | -- | 0.9037 | -- | 13.57 | -0.2317 | 87.72 | -- | -24.93 | -- |
| Context Therapeutics Inc | 0.00 | -26.44m | 211.32m | 12.00 | -- | 2.89 | -- | -- | -0.2835 | -0.2835 | 0.00 | 0.7964 | 0.00 | -- | -- | 0.00 | -31.94 | -44.73 | -33.64 | -57.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.52 | -- | -- | -- |
| Quantum-Si Inc | 3.18m | -116.85m | 213.46m | 143.00 | -- | 0.9076 | -- | 67.19 | -0.6589 | -0.6589 | 0.0176 | 1.09 | 0.0128 | 0.404 | 3.58 | 22,216.78 | -47.06 | -- | -50.90 | -- | 51.65 | -- | -3,677.97 | -11,135.53 | 10.59 | -- | 0.00 | -- | 182.62 | -- | -5.26 | -- | -- | -- |
| Achieve Life Sciences Inc | 0.00 | -52.35m | 223.58m | 25.00 | -- | 6.60 | -- | -- | -1.38 | -1.38 | 0.00 | 0.6365 | 0.00 | -- | -- | 0.00 | -104.74 | -95.73 | -125.36 | -142.31 | -- | -- | -- | -- | -- | -- | 0.2271 | -- | -- | -- | -33.58 | -- | -- | -- |
| Nuvectis Pharma Inc | 0.00 | -28.87m | 232.07m | 13.00 | -- | 12.22 | -- | -- | -1.31 | -1.31 | 0.00 | 0.7171 | 0.00 | -- | -- | 0.00 | -105.10 | -123.50 | -188.03 | -201.07 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -51.95 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Quantum-Si Inc's reporting currency: US Dollar USD
24.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 12.09m | 6.18% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 8.41m | 4.30% |
| ARK Investment Management LLCas of 31 Dec 2025 | 7.02m | 3.59% |
| Amova Asset Management Americas, Inc.as of 31 Dec 2025 | 4.69m | 2.40% |
| Geode Capital Management LLCas of 31 Dec 2025 | 4.11m | 2.10% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 3.56m | 1.82% |
| Millennium Management LLCas of 30 Sep 2025 | 2.67m | 1.37% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2025 | 2.32m | 1.19% |
| Susquehanna Financial Group LLLPas of 30 Sep 2025 | 2.01m | 1.03% |
| UBS Securities LLCas of 31 Dec 2025 | 1.41m | 0.72% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
